linkedin
BROUGHT TO YOU BY
Exclusive Access, Inclusive Growth

WELCOME TO ET PRIME

BROUGTH TO YOU BY
Exclusive Access, Inclusive Growth
ET Prime
Policy and regulations

India's drug-pricing authority appears headed for its expiry date

No legal support. No clear vision for the future. The once fearsome regulator seems to be waiting for decommissioning. ET Prime brings you the inside story.
font size
FONT SIZE
save
SAVE
saved
SAVED
Gift this article
GIFT ARTICLE
anujgupta
22 Jun 2018 6 Mins Read 0 comment
Rakesh Kumar Vats, Chairman, National Pharmaceutical Pricing Authority. Image courtesy: HLL Lifecare
Rakesh Kumar Vats, Chairman, National Pharmaceutical Pricing Authority. Image courtesy: HLL Lifecare
Hidden inside the bowels of India’s bureaucracy is a body with a high-voltage name: National Authority for Chemical Weapons Convention. Its job? " Implementing the provisions of the Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on their Destruction, signed on behalf of the Government of India at Paris on the 14th day
heading the regulatory body (NPPA), which gives [us] hope that the organisation will transform into a body that looks [at] a futuristic and aspirational India [and takes] decisions from the angle of health outcomes, taking into account the cost effectiveness and safety of treatments."Interestingly, the dialogue between medical-device importers and related government bodies have increased substantially in last two-three months.
Hidden inside the bowels of India’s bureaucracy is a body with a high-voltage name: National Authority for Chemical Weapons Convention. Its job? " Implementing the provisions of the Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on their Destruction, signed on behalf of the Government of India at Paris on the 14th day heading the regulatory body (NPPA), which gives [us] hope that the organisation will transform into a body that looks [at] a futuristic and aspirational India [and takes] decisions from the angle of health outcomes, taking into account the cost effectiveness and safety of treatments."Interestingly, the dialogue between medical-device importers and related government bodies have increased substantially in last two-three months.

The latest from ET Prime is now on Telegram. To subscribe to our Telegram newsletter click here.

Gift this story

YOU CAN GIFT 0 MORE STORIES THIS MONTH

Maximum 10 Email IDs allowed

300 characters remaining

Gift Sent Successfully

Limit Reached
Limit Reached

You’ve gifted all the 0 articles from your monthly gift bucket!

Please come back next month.

0 more articles will be waiting for you in your gift bucket.

Current Edition

[[^message]]

Result

[[/message]] [[#message]]

[[message]]

[[/message]]